Bengaluru, Karnataka, India, May 05, 2017:
Kiran Mazumdar-Shaw, Chairperson & Managing Director of Biocon Ltd., has been bestowed with the ‘AWSM Award for Excellence 2017’ by the Advancing Women in Science and Medicine (AWSM) wing of The Feinstein Institute for Medical Research, USA. She is the first Indian woman to win this prestigious award that is dedicated to celebrating outstanding women in science and medicine.
Ms. Mazumdar-Shaw received the award at the 6th Annual AWSM Awards held in New York City, on May 4, for the global impact she has made as an entrepreneur and humanist to healthcare globally and for serving as a role model for women in medicine and science.
Speaking on the occasion, Ms. Kiran Mazumdar-Shaw, CMD of Biocon, said, “I am honoured to receive the ‘AWSM Award for Excellence 2017’ and consider it a great privilege to be in the company of inspiring women scientists who have made deep and path-breaking contributions in the field of science and medicine. I thank the Feinstein Institute’s Advancing Women in Science and Medicine (AWSM) organization for this award and dedicate it to the thousands of women scientists all around the world who are working passionately to make a difference to global health.”
More recently, Ms. Kiran Mazumdar-Shaw was featured on ‘The Medicine Maker Power List 2017’ for the third consecutive year. This year she was ranked amongst Top 3 ‘Business Captains’ and ‘Overall Top 10’ for her global influence. ‘The Medicine Maker Power List’ is an index of the 100 most influential people across the globe in the field of medicine and Ms. Mazumdar-Shaw is recognized for her contribution to the world of medicine as an entrepreneur and leader.
Ms. Mazumdar-Shaw is a pioneer of the biotechnology industry in India and the founder of the country’s leading biotechnology enterprise, Biocon. Named among TIME magazine’s 100 most influential people in the world, Ms. Mazumdar-Shaw is recognized for her contributions in harnessing the power of Biotechnology to provide affordable access to best-in-class, life-saving biopharmaceuticals for patients across the globe. Her rich contributions to research, innovation and affordable healthcare have been recognized by with several national and international awards. Most recently, she was conferred with the highest French distinction – Chevalier de l’Ordre National de la Légion d’Honneur (Knight of the Legion of Honour).
Each year, AWSM honors a woman who has made a difference to biomedical science. Past recipients include Drs. Anne Young, Laurie Glimcher, Cori Bargmann, and Jennifer Doudna.
AWSM is an organization of female scientists at the Feinstein Institute for Medical Research, a private, non-profit institution. It runs research programs focusing on immunology, inflammation, neuroscience, and behavioural medicine. AWSM is passionate about developing and implementing transformative research programs focussed on improving human health.
About The Feinstein Institute for Medical Research:
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 3,500 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information visit: FeinsteinInstitute.org.